Wafra Inc. Moderna, Inc. Transaction History

Wafra Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$135.66 - $197.02 $7.09 Million - $10.3 Million	-52,253 Reduced 55.59%	41,740 $6.41 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $890,422 - $1.34 Million	7,602 Added 8.8%	93,993 $13.4 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $7.26 Million - $13.5 Million	57,415 Added 198.15%	86,391 $14.9 Million
Q4 2021 Feb 17, 2022	SELL	$225.82 - $368.51 $9.62 Million - $15.7 Million	-42,617 Reduced 59.53%	28,976 $7.36 Million
Q3 2021 Nov 08, 2021	BUY	$221.9 - $484.47 $15.9 Million - $34.7 Million	71,593 New	71,593 $27.6 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

Stay updated on Wafra Inc. with notifications on news.